Vaxcyte, Inc. — Director's Dealing 2021

Sep 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2021-09-16

Reporting Person: Drapeau Anne S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-16	Stock Option (Right to Buy)	$26.37	A	30000	Acquired	2031-09-15	Common Stock (30000)	Direct

Footnotes

F1: Option shall vest over 36 months, 1/3 of which will vest on September 16, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date